GlassScriptPhysician profile
David A Wilson
NPI 1265428445
$13,142.71
in general payments reported to CMS, 2019-2025
35 companies · $1,998 in 2025
The $1,998 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,858 · 2020: $615 · 2021: $2,355 · 2022: $1,156 · 2023: $1,080 · 2024: $4,080 · 2025: $1,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,173 · Travel and Lodging: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,172.63 |
| Travel and Lodging | $985.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,614.13 | 2019-2025 | Aveir, Ensite Precision, Jot Dx |
| Boston Scientific Corporation | $2,111.76 | 2019-2025 | Watchman Flx, Farapulse, General - Therapies |
| Biosense Webster, INC. | $1,718.58 | 2019-2025 | Carto 3, Qdot Micro Catheter, Soundstar |
| Acutus Medical, INC. | $1,447.98 | 2021-2023 | |
| Medtronic, INC. | $1,280.02 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Affera Mapping System |
| Medtronic Vascular, INC. | $864.72 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $306.15 | 2019-2024 | Eliquis, Camzyos |
| Cardiva Medical, INC. | $262.95 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $179.10 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $174.65 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $125.11 | 2022-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.10 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $122.83 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $107.59 | 2020-2021 | |
| Preventice Services, LLC | $98.79 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $85.36 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $74.99 | 2021-2025 | Farxiga, Wainua |
| Amgen INC. | $52.07 | 2022-2024 | Repatha |
| Covidien LP | $39.97 | 2019 | |
| Edwards Lifesciences Corporation | $39.34 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Cvrx, INC. | $38.06 | 2023-2024 | Barostim Neo System |
| Biotronik INC. | $34.03 | 2021 | |
| Portola Pharmaceuticals, LLC | $33.20 | 2019 | |
| Impulse Dynamics (USA) INC. | $28.66 | 2022 | |
| Vital Connect, INC | $22.73 | 2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $21.17 | 2024 | Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $21.00 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $17.20 | 2024 | |
| Amarin Pharma, INC. | $16.08 | 2020 | |
| Esperion Therapeutics, INC. | $14.78 | 2023 | Nexletol |
| Altathera Pharmaceuticals LLC | $14.54 | 2025 | Sotalol Hydrochloride |
| Heartflow, INC. | $14.18 | 2023 | Ffrct |
| Cordis US Corp. | $13.78 | 2024 | Mynx Control |
| W. L. Gore & Associates, INC. | $11.50 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.